Latham & Watkins Advises on ICON’s US$2.15 Billion Senior Notes Offering

ICON plc (Nasdaq: ICLR), a world‑leading clinical research organization, has announced the pricing by its wholly owned subsidiary, ICON Investments Six Designated Activity Company, of US$2.15 billion of senior unsecured notes, consisting of US$500 million aggregate principal amount of 5.064% notes due 2029, US$1 billion aggregate principal amount of 5.421% notes due 2031, and US$650 million aggregate principal amount of 5.995% notes due 2036. The offering is expected to close on August 13, 2026, subject to the satisfaction of customary closing conditions.

Latham & Watkins LLP represents the initial purchasers in the transaction with a Capital Markets team led by partner Erika Weinberg, with associates Robyn Sablove, Rachel Moore, and Jackie Stern. Advice was also provided on tax matters by New York partner Bora Bozkurt, with associate Shiyi Parsons; on FDA regulatory matters by counsel Chad Jennings; on healthcare matters by partner Betty Pang; and on data privacy and cybersecurity matters by partner Heather Deixler, with associate Ryleigh Chen.